65 related articles for article (PubMed ID: 8218985)
1. Quantitative approach to the immunohistochemical analysis of p53 antioncogene and CD30 antigen in Hodgkin' disease.
Chilosi M; Montagna L; Lestani M; Menestrina F; Mariuzzi GM
In Vivo; 1993; 7(4):393-4. PubMed ID: 8218985
[TBL] [Abstract][Full Text] [Related]
2. Morphologically normal, CD30-negative B-lymphocytes with chromosome aberrations in classical Hodgkin's disease: the progenitor cell of the malignant clone?
Jansen MP; Hopman AH; Bot FJ; Haesevoets A; Stevens-Kroef MJ; Arends JW; Jox A; Wolf J; Ramaekers FC; Schouten HC
J Pathol; 1999 Dec; 189(4):527-32. PubMed ID: 10629553
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evidence of abnormal expression of the antioncogene-encoded p53 phosphoprotein in Hodgkin's disease and CD30+ anaplastic lymphomas.
Doglioni C; Pelosio P; Mombello A; Scarpa A; Chilosi M
Hematol Pathol; 1991; 5(2):67-73. PubMed ID: 1680118
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin's lymphoma of T-cell type: clonal association with a CD30+ cutaneous lymphoma.
Kadin ME; Drews R; Samel A; Gilchrist A; Kocher O
Hum Pathol; 2001 Nov; 32(11):1269-72. PubMed ID: 11727269
[TBL] [Abstract][Full Text] [Related]
5. Aberrant FHIT protein expression in classical Hodgkin's lymphoma: a potential marker.
Zhao P; Lam AK; Lu YL; Zhong M; Chen LH; Pu XL
Pathology; 2006 Oct; 38(5):399-402. PubMed ID: 17008276
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-negative Hodgkin's lymphoma after mycosis fungoides: molecular evidence for distinct clonal origin.
Kremer M; Sandherr M; Geist B; Cabras AD; Höfler H; Fend F
Mod Pathol; 2001 Feb; 14(2):91-7. PubMed ID: 11235910
[TBL] [Abstract][Full Text] [Related]
7. CD30 expression utilization for the accuracy of classical Hodgkin's lymphoma staging.
Flangea C; Potencz E; Mihăescu R; Anghel A; Gîju S; Motoc M; Dogaru C
Rom J Morphol Embryol; 2006; 47(2):113-7. PubMed ID: 17106517
[TBL] [Abstract][Full Text] [Related]
8. Percentage of proliferating cell nuclear antigen (PCNA)-positive Reed-Sternberg cells in nodular sclerosis Hodgkin's disease.
Kordek R; Biernat W; Niewiadomska H; Kupnicka D; Woźniak L; Domagała W; Osborn M
Patol Pol; 1993; 44(3):129-31. PubMed ID: 7902558
[TBL] [Abstract][Full Text] [Related]
9. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.
Smolewski P; Niewiadomska H; Błonski JZ; Robak T; Krykowski E
Neoplasma; 1998; 45(3):140-7. PubMed ID: 9717525
[TBL] [Abstract][Full Text] [Related]
10. CD30 in normal and neoplastic cells.
Chiarle R; Podda A; Prolla G; Gong J; Thorbecke GJ; Inghirami G
Clin Immunol; 1999 Feb; 90(2):157-64. PubMed ID: 10080826
[TBL] [Abstract][Full Text] [Related]
11. Nodular lymphocyte predominant Hodgkin's disease and anaplastic large-cell (CD30+) lymphoma: distinct entities or nonspecific patterns?
Menestrina F; Chilosi M; Scarpa A
Semin Diagn Pathol; 1995 Aug; 12(3):256-69. PubMed ID: 8545592
[TBL] [Abstract][Full Text] [Related]
12. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
Brink AA; Oudejans JJ; van den Brule AJ; Kluin PM; Horstman A; Ossenkoppele GJ; van Heerde P; Jiwa M; Meijer CJ
Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease: a paraffin-section immunohistochemical study using the heat-induced epitope retrieval method.
Vasef MA; Alsabeh R; Medeiros LJ; Weiss LM
Am J Clin Pathol; 1997 Jul; 108(1):54-9. PubMed ID: 9208978
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of light chain mRNA in Hodgkin's disease.
Hell K; Pringle JH; Hansmann ML; Lorenzen J; Colloby P; Lauder I; Fischer R
J Pathol; 1993 Oct; 171(2):137-43. PubMed ID: 8283350
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of imprint cytology in the assessment of Hodgkin's disease in Japan.
Funamoto Y; Nagai M; Haba R; Ishikawa M; Kishida F; Kohno K; Matsunaga T; Kushida Y; Kobayashi S
Diagn Cytopathol; 2005 Jul; 33(1):20-5. PubMed ID: 15945083
[TBL] [Abstract][Full Text] [Related]
16. An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
Klimka A; Barth S; Matthey B; Roovers RC; Lemke H; Hansen H; Arends JW; Diehl V; Hoogenboom HR; Engert A
Br J Cancer; 1999 Jun; 80(8):1214-22. PubMed ID: 10376974
[TBL] [Abstract][Full Text] [Related]
17. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
18. Translocation t(2;5) is not a primary event in Hodgkin's disease. Simultaneous immunophenotyping and interphase cytogenetics.
Weber-Matthiesen K; Deerberg-Wittram J; Rosenwald A; Poetsch M; Grote W; Schlegelberger B
Am J Pathol; 1996 Aug; 149(2):463-8. PubMed ID: 8701985
[TBL] [Abstract][Full Text] [Related]
19. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
[TBL] [Abstract][Full Text] [Related]
20. p53 protein expression in Reed-Sternberg cells of Hodgkin's disease.
Gupta RK; Norton AJ; Lister TA; Bodmer JG
Leukemia; 1993 Aug; 7 Suppl 2():S31-3. PubMed ID: 8361229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
